Anti-Sulfotyrosine antibody [Sulfo-1C-A2]
Be the first to review this product! Submit a review
|
(4 Publications)
- WB
Unknown
Western blot - Anti-Sulfotyrosine antibody [Sulfo-1C-A2] (AB136481)
Lanes 1 - 3:
control IgG
Lanes 4 - 6:
Western blot - Anti-Sulfotyrosine antibody [Sulfo-1C-A2] (ab136481) at 1/1000 dilution
Lanes 1 and 4:
3T3/NIH cell lysate
Lanes 2 and 5:
HEK 293 cell lysate
Lanes 3 and 6:
Bovine cardiac tissue lysate
Secondary
All lanes:
Goat anti-mouse secondary antibody conjugated to HRP at 1/2000 dilution
true
- WB
Unknown
Western blot - Anti-Sulfotyrosine antibody [Sulfo-1C-A2] (AB136481)
All lanes:
Western blot - Anti-Sulfotyrosine antibody [Sulfo-1C-A2] (ab136481) at 1/1000 dilution
Lane 1:
Purified bovine fibrinogen treated with 1.5 mg/ml abalone sulfatase at 37°C overnight.
Lane 2:
Purified bovine fibrinogen
Secondary
All lanes:
Goat anti-mouse secondary antibody conjugated to HRP at 1/2000 dilution
true
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The sulfotyrosine modification significantly enhances the binding properties of proteins involved in diverse biological processes. It affects proteins such as adhesion molecules G protein-coupled receptors and coagulation factors often being essential for their proper function. Many proteins containing sulfotyrosine participate in forming multi-protein complexes that mediate cell signaling and communication.
Pathways
Sulfotyrosine modifications integrate notably into signal transduction and immune response pathways. Proteins like P-selectin glycoprotein ligand-1 (PSGL-1) and chemokine receptors such as CCR5 require sulfotyrosine for optimal receptor-ligand interactions which impacts leukocyte trafficking and chemotaxis. These modifications often serve as docking sites for other proteins coordinating complex pathways important for cellular responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Molecular cancer 23:155 PubMed39095793
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 10:19818 PubMed33188246
2020
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 294:11087-11100 PubMed31152061
2019
Applications
Unspecified application
Species
Unspecified reactive species
Molecular & cellular proteomics : MCP 17:2480-2495 PubMed30097533
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com